151 related articles for article (PubMed ID: 12181248)
1. Loss of cyclin D1 and p16 expression correlates with local recurrence in nasopharyngeal carcinoma following radiotherapy.
Hwang CF; Cho CL; Huang CC; Wang JS; Shih YL; Su CY; Chang HW
Ann Oncol; 2002 Aug; 13(8):1246-51. PubMed ID: 12181248
[TBL] [Abstract][Full Text] [Related]
2. Concomitant analysis of p16/INK4, cyclin D1, and retinoblastoma protein expression in esophageal squamous cell carcinoma.
Nakamura T; Ide H; Eguchi R; Hayashi K; Takasaki K
Hepatogastroenterology; 2003; 50(53):1321-6. PubMed ID: 14571727
[TBL] [Abstract][Full Text] [Related]
3. Disruption of the p16/cyclin D1/retinoblastoma protein pathway in the majority of human hepatocellular carcinomas.
Azechi H; Nishida N; Fukuda Y; Nishimura T; Minata M; Katsuma H; Kuno M; Ito T; Komeda T; Kita R; Takahashi R; Nakao K
Oncology; 2001; 60(4):346-54. PubMed ID: 11408803
[TBL] [Abstract][Full Text] [Related]
4. Cyclin D1 amplification is independent of p16 inactivation in head and neck squamous cell carcinoma.
Okami K; Reed AL; Cairns P; Koch WM; Westra WH; Wehage S; Jen J; Sidransky D
Oncogene; 1999 Jun; 18(23):3541-5. PubMed ID: 10376532
[TBL] [Abstract][Full Text] [Related]
5. Alterations of rb pathway components are frequent events in patients with oral epithelial dysplasia and predict clinical outcome in patients with squamous cell carcinoma.
Soni S; Kaur J; Kumar A; Chakravarti N; Mathur M; Bahadur S; Shukla NK; Deo SV; Ralhan R
Oncology; 2005; 68(4-6):314-25. PubMed ID: 16020958
[TBL] [Abstract][Full Text] [Related]
6. Identification of aberrant cell cycle regulation in Epstein-Barr virus-associated nasopharyngeal carcinoma by cDNA microarray and gene set enrichment analysis.
Zhang W; Zeng Z; Zhou Y; Xiong W; Fan S; Xiao L; Huang D; Li Z; Li D; Wu M; Li X; Shen S; Wang R; Cao L; Tang K; Li G
Acta Biochim Biophys Sin (Shanghai); 2009 May; 41(5):414-28. PubMed ID: 19430707
[TBL] [Abstract][Full Text] [Related]
7. Abnormal expression of p16(INK4a), cyclin D1, cyclin-dependent kinase 4 and retinoblastoma protein in gastric carcinomas.
Kishimoto I; Mitomi H; Ohkura Y; Kanazawa H; Fukui N; Watanabe M
J Surg Oncol; 2008 Jul; 98(1):60-6. PubMed ID: 18484097
[TBL] [Abstract][Full Text] [Related]
8. The role of pRB, p16 and cyclin D1 in colonic carcinogenesis.
Ayhan S; Isisag A; Saruc M; Nese N; Demir MA; Kucukmetin NT
Hepatogastroenterology; 2010; 57(98):251-6. PubMed ID: 20583423
[TBL] [Abstract][Full Text] [Related]
9. Alterations of expression of Rb, p16(INK4A) and cyclin D1 in non-small cell lung carcinoma and their clinical significance.
Brambilla E; Moro D; Gazzeri S; Brambilla C
J Pathol; 1999 Aug; 188(4):351-60. PubMed ID: 10440744
[TBL] [Abstract][Full Text] [Related]
10. Further evidence that altered p16/CDKN2 gene expression is associated with lymph node metastasis in squamous cell carcinoma of the esophagus.
Takeuchi H; Ozawa S; Ando N; Kitagawa Y; Mukai M; Ueda M; Kitajima M
Oncol Rep; 2001; 8(3):627-32. PubMed ID: 11295092
[TBL] [Abstract][Full Text] [Related]
11. Reduced p16 and increased cyclin D1 and pRb expression are correlated with progression in cutaneous melanocytic tumors.
Karim RZ; Li W; Sanki A; Colman MH; Yang YH; Thompson JF; Scolyer RA
Int J Surg Pathol; 2009 Oct; 17(5):361-7. PubMed ID: 19666944
[TBL] [Abstract][Full Text] [Related]
12. Alterations of the p16/Rb/cyclin-D1 pathway in vulvar carcinoma, vulvar intraepithelial neoplasia, and lichen sclerosus.
Lerma E; Esteller M; Herman JG; Prat J
Hum Pathol; 2002 Nov; 33(11):1120-5. PubMed ID: 12454817
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of key cell cycle genes (p16/cyclin D1/pRb) in head and neck squamous carcinomas.
Lai S; El-Naggar AK
Lab Invest; 1999 Mar; 79(3):255-60. PubMed ID: 10092061
[TBL] [Abstract][Full Text] [Related]
14. Expression of pRb, p53, p16 and cyclin D1 and their clinical implications in urothelial carcinoma.
Lee K; Jung ES; Choi YJ; Lee KY; Lee A
J Korean Med Sci; 2010 Oct; 25(10):1449-55. PubMed ID: 20890425
[TBL] [Abstract][Full Text] [Related]
15. Reduced expression of p16 and p27 proteins in nasopharyngeal carcinoma.
Baba Y; Tsukuda M; Mochimatsu I; Furukawa S; Kagata H; Satake K; Koshika S; Nakatani Y; Hara M; Kato Y; Nagashima Y
Cancer Detect Prev; 2001; 25(5):414-9. PubMed ID: 11718447
[TBL] [Abstract][Full Text] [Related]
16. Association of cyclin D1, p16 and retinoblastoma protein expressions with prognosis and metastasis of gallbladder carcinoma.
Ma HB; Hu HT; Di ZL; Wang ZR; Shi JS; Wang XJ; Li Y
World J Gastroenterol; 2005 Feb; 11(5):744-7. PubMed ID: 15655836
[TBL] [Abstract][Full Text] [Related]
17. Disruption of the RB pathway and cell-proliferative activity in non-small-cell lung cancers.
Tanaka H; Fujii Y; Hirabayashi H; Miyoshi S; Sakaguchi M; Yoon HE; Matsuda H
Int J Cancer; 1998 Apr; 79(2):111-5. PubMed ID: 9583722
[TBL] [Abstract][Full Text] [Related]
18. Results of immunohistochemical staining of cell-cycle regulators: the prediction of recurrence of functioning pituitary adenoma.
Lee EH; Kim KH; Kwon JH; Kim HD; Kim YZ
World Neurosurg; 2014; 81(3-4):563-75. PubMed ID: 24067736
[TBL] [Abstract][Full Text] [Related]
19. Alterations of the cyclin D1/pRb/p16(INK4A) pathway in multiple myeloma.
Krämer A; Schultheis B; Bergmann J; Willer A; Hegenbart U; Ho AD; Goldschmidt H; Hehlmann R
Leukemia; 2002 Sep; 16(9):1844-51. PubMed ID: 12200702
[TBL] [Abstract][Full Text] [Related]
20. Alterations in cyclin D1 expression in esophageal squamous cell carcinoma in the Indian population.
Mathew R; Arora S; Khanna R; Shukla NK; Mathur M; Ralhan R
J Cancer Res Clin Oncol; 2001 Apr; 127(4):251-7. PubMed ID: 11315260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]